SCHEMBL25046191

SCHEMBL25046191

N#Cc1ccc(N)c(NC(N)=S)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.41
▸ KDM4E B2RXH2 3/20 0.41
▸ GAA P10253 2/20 0.41
▸ IDO1 P14902 2/20 0.41
▸ MAPT P10636 3/20 0.38
▸ HDAC1 Q13547 2/20 0.37
▸ HDAC2 Q92769 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ KMT2A Q03164 5/20 0.37
▸ MEN1 O00255 4/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ ALOX12 P18054 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ CXCR1 P25024 1/20 0.34
▸ CXCR2 P25025 1/20 0.34
▸ TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18974769 0.78 USP30 (0.42) ALDH1A1KDM4EGAAIDO1MAPT
SCHEMBL18974772 0.78 L3MBTL1 (0.51) ALDH1A1KDM4EGAAIDO1MAPT
SCHEMBL13992667 0.78 PDK1 (0.51) ALDH1A1KDM4EGAAIDO1MAPT
SCHEMBL6113932 0.78 AR (0.42) KMT2A
SCHEMBL28344665 0.76 L3MBTL1 (0.42) ALDH1A1KDM4EGAAMAPTL3MBTL1
SCHEMBL20888953 0.76 KDM4E (0.47) ALDH1A1KDM4EGAAIDO1MAPT
SCHEMBL6114102 0.74 ALDH1A1 (0.41) ALDH1A1IDO1MAPTHDAC1KMT2A
SCHEMBL21992444 0.74 KDM4E (0.46) ALDH1A1KDM4EGAAIDO1MAPT
SCHEMBL2248326 0.74 ALDH1A1 (0.46) ALDH1A1KDM4EGAAKMT2AMEN1
SCHEMBL11164984 0.73 MAPT (0.46) ALDH1A1KDM4EGAAMAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023018636-A1 COMPOUNDS THAT INHIBIT PI3K ISOFORM ALPHA AND METHODS FOR TREATING CANCER SCORPION THERAPEUTICS, INC. (US) 2023-02-16 — — WO disclosed
Send feedback